Vasoactive Peptides in Portal Pressure

Bayside Health

Status: Unknown

Conditions: Portal Hypertension

Treatments: Drug: Norfloxacin

Study type: Interventional

Funder types: Other

Identifiers

NCT00163982

AH4204

Details and patient eligibility

About

This study is looking at the detection of vasoactive peptides in portal hypertension.

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• HVPG >= 12 mmHg

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind